Cover Image

Editorial: Defining corticosteroid use in clinical trials

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Author:	J. Siffledeen
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Alimentary Pharmacology & Therapeutics
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety of risankizumab by baseline corticosteroid use and achievement of corticosteroid‐free clinical and endoscopic outcomes in patients with moderately to severely active Crohn's disease
by: Stefan Schreiber, et al.
Published: (2024)

Bisphosphonate effectiveness in patients with cirrhosis: An emulated clinical trial
by: Elliot B. Tapper, et al.
Published: (2024)

A personalised algorithm predicting the risk of intravenous corticosteroid failure in acute ulcerative colitis
by: Anthony Croft, et al.
Published: (2024)

Letter: Bisphosphonate effectiveness in patients with cirrhosis—An emulated clinical trial
by: Mingsi Zhang, et al.
Published: (2024)

Letter: Bisphosphonate effectiveness in patients with cirrhosis—an emulated clinical trial. Authors' reply
by: Elliot B. Tapper, et al.
Published: (2024)

Randomised clinical trial: Design of the SYNERGY‐NASH phase 2b trial to evaluate tirzepatide as a treatment for metabolic dysfunction‐associated steatohepatitis and modification of screening strategy to reduce screen failures
by: Raj Vuppalanchi, et al.
Published: (2024)

An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor‐induced liver injury
by: Mar Riveiro‐Barciela, et al.
Published: (2024)

Review article: Recommendations for detection, assessment and management of suspected drug‐induced liver injury during clinical trials in oncology patients
by: Anna Fettiplace, et al.
Published: (2024)

Editorial: Redefining liver health—Personalised approach to assessment of serum ALT in clinical practice
by: Basile Njei, et al.
Published: (2024)

Editorial: Redefining liver health—Personalised approach to assessment of serum ALT in clinical practice. Authors' reply
by: Eunice X. X. Tan, et al.
Published: (2024)

Outcomes of patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab in real‐world clinical practice who met or did not meet the inclusion criteria for the phase 3 IMbrave150 trial
by: Toshifumi Tada, et al.
Published: (2024)

Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound
by: Cathy Lu, et al.
Published: (2024)

Editorial: Incidence and predictors of major gastrointestinal bleeding in patients on aspirin, low‐dose rivaroxaban or the combination: Secondary analysis of the COMPASS randomised controlled trial
by: Kanika Sehgal, et al.
Published: (2024)

Clinical trial: The effectiveness of long‐acting somatostatin analogue for output reduction of high‐output intestinal fistula or small bowel enterostomy. A randomised controlled trial
by: Allard S. Timmer, et al.
Published: (2024)

Identification of four novel acute‐on‐chronic liver failure clusters with distinct clinical trajectories and mortality using machine learning methods
by: Nipun Verma, et al.
Published: (2024)

Editorial: Leveraging existing mid‐end ultrasound machine for point‐of‐care intestinal ultrasound in low‐resource settings: Prospective, real‐world impact on clinical decision making. Authors' reply
by: Partha Pal, et al.
Published: (2024)

Letter: Presence of progression or absence of response? Alternative trial designs for immunotherapy of advanced hepatocellular carcinoma
by: Enrico N. De Toni, et al.
Published: (2024)

Long‐term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study
by: María Chaparro, et al.
Published: (2024)

Review article: The epidemiology and management of Clostridioides difficile infection—A clinical update
by: Lindsay M. Clarke, et al.
Published: (2024)

Editorial: Disorders of gut‐brain interaction—Don't forget the older person
by: Christopher J. Black
Published: (2024)

Editorial: The Devil Is in the Detail—Interpreting the Findings of Network Meta‐Analyses
by: Christy Riggott, et al.
Published: (2025)

Letter: Social work and clinical synergy—Optimising health interventions for elderly DGBI populations
by: Rui Zhang, et al.
Published: (2024)

Editorial: Surgery to reduce opioid use in Crohn's disease: Does a classic solution address a newer problem?
by: Tarun Chhibba
Published: (2024)

Letter: Ulcerative proctitis—A step towards addressing the knowledge gap, and a call for greater detail, in trial data
by: John David Chetwood, et al.
Published: (2024)

Eight‐year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials
by: Maria Buti, et al.
Published: (2024)

Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction‐associated steatotic liver disease
by: Nabil Noureddin, et al.
Published: (2024)

Editorial: Navigating the Beta‐Blocker Dilemma in Advanced Liver Cirrhosis—When Is the Right Time to Discontinue?
by: Louise J. M. Alferink, et al.
Published: (2024)

Editorial: Using HBcrAg and HBsAg Kinetics to Optimise Monitoring After Nucleo(s)tide Analogue Withdrawal
by: Edo J. Dongelmans, et al.
Published: (2026)

Editorial: Obesity and Outcomes on Advanced Therapy in Ulcerative Colitis—The Fat of the Matter
by: Anish J. Kuriakose Kuzhiyanjal, et al.
Published: (2025)

Editorial: Can we predict or not predict response to hypnotherapy? That is the question. Authors' reply
by: Dipesh H. Vasant, et al.
Published: (2024)

Editorial: Chronic Hepatitis Delta—We Need More Screening to Improve Knowledge on the Natural History
by: J. Ventre, et al.
Published: (2025)

Letter: Social work and clinical synergy—Optimizing health interventions for elderly DGBI populations: Authors' reply
by: Ami D. Sperber, et al.
Published: (2024)

Editorial: Ulcerative Colitis Management in the Biologic Era–Data From the English Healthcare Databases. Authors' Reply
by: J. Couch, et al.
Published: (2025)

Letter: Ulcerative proctitis—A step towards addressing the knowledge gap, and a call for greater detail, in trial data—Authors' reply
by: Rocío Ferreiro‐Iglesias, et al.
Published: (2024)

Editorial: Intestinal Ultrasound for the Assessment of Constipation—Out of the Shadows?
by: J. M. B. W. Vos, et al.
Published: (2025)

Letter: Baseline age on antiviral treatment may significantly influence the clinical response of children with chronic hepatitis B
by: Jing Li, et al.
Published: (2024)

Editorial: When and What to Ask—Capturing the Symptoms Experienced by Patients With PSC. Authors' Reply
by: Natassia Tan, et al.
Published: (2025)

Editorial: Quantity is important!
by: Chee‐Kiat Tan
Published: (2024)

Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis ‐ prevalence, clinical impact, economic implications and management strategies
by: Pegah Golabi, et al.
Published: (2024)

Editorial: TIPS in the Era of Aging and Metabolic Comorbidity—Rethinking Risks and Rewards. Authors Reply
by: Michelle Spaan, et al.
Published: (2026)